Reacción #51541
ord-df69efdc1db442458306952e98924054
Ecuación de reacción
Reactantes
Reactivos
Disolventes
Condiciones de reacción
Tratamiento posterior
- 1workup.WAITwith warning to ambient temperature for several hours
- 2Otroquenched with sat'd ammonium chloride
- 3ExtracciónExtracted with ethyl acetate
- 4Lavadowashed organics with brine
- 5Secadodried (MgSO4)
- 6Concentraciónconcentrated
- 7OtroThe residue was purified by prep HPLC (
- 8LavadoC18 reverse phase column, elution with a H2O/CH3CN gradient with 0.5% TFA)
- 9workup.ADDITIONFractions containing desired compound
- 10Extracciónextracted with ethyl acetate
- 11Secadodried (MgSO4)
- 12Concentraciónconcentrated
Procedimiento
To a solution of 2-[(7bR,11aS)-1,2,7b,8,9,10,11,11a-octahydro-4H-pyrido[4,3-b)[1,4]thiazepino[6,5,4-hi]indol-6-yl]-5-methoxybenzaldehyde, the free base of EXAMPLE 16 (0.03 g, 0.08 mmol), in 5 mL of tetrahydrofuran at 0° C. was added methyl magnesium bromide (0.52 mL of a 3M solution in THF, 1.58 mmol). Stirred with warning to ambient temperature for several hours and then quenched with sat'd ammonium chloride. Extracted with ethyl acetate, washed organics with brine, dried (MgSO4) and concentrated. The residue was purified by prep HPLC (C18 reverse phase column, elution with a H2O/CH3CN gradient with 0.5% TFA). Fractions containing desired compound were then immediately free based with 1 N sodium hydroxide, extracted with ethyl acetate, dried (MgSO4) and concentrated to afford the title compound of EXAMPLE 21. LRMS (ES+): 397.1 (M+H)+.